Revance Therapeutics scores 35th spot on Deloitte's Technology Fast 500 List, with major revenue growth
Published
Revance Therapeutics has taken the 35th spot on Deloitte’s 2021 Technology Fast 500 list, which ranks the 500 fastest growing public and private companies in North America. Deloitte bases the ranking on percentage fiscal year growth over a three-year period.
Full Article